Corrections

Consumer group calls for antidiabetes drug to be withdrawn

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e3370 (Published 11 May 2012) Cite this as: BMJ 2012;344:e3370

A few errors made it into this News story by Jeanne Lenzer (BMJ 2012;344:e3259, doi:10.1136/bmj.e3259). In the second paragraph it should have read that Public Citizen’s Health Research Group said that liraglutide is associated with higher than expected risks [not rates] of pancreatitis, thyroid cancer, and kidney failure. In the fourth paragraph the last sentence should have been: “The FDA [not she] also cited concerns about possible associations with thyroid and pancreatic cancer, kidney failure, and serious allergic reactions.” Lastly, Sidney Wolfe’s comment that was quoted in the penultimate paragraph as “Novo Nordisk’s ads make Victoza sound like it’s a piece of cake since you can inject once a day instead of twice daily with insulin” should have been “Novo Nordisk’s ads make Victoza sound like it’s a piece of cake since you can inject just once a day.”

Notes

Cite this as: BMJ 2012;344:e3370

View Abstract